2m 2m 2m 2m 2m 2m 2m
AQUESTIVE THERP (AQST)
NASDAQ
$3.95+$0.02 (+0.51%)
Price as of Jun 03, 2026 5:35 PM EDT- $504.3MMarket Cap
- 23.58%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AQUESTIVE THERP (AQST)
$3.95+$0.02 (+0.51%)
AQST | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.93 | ||
Change | -$0.07 (-1.75%) | ||
Open | $3.98 | ||
High | $3.98 | ||
Low | $3.87 | ||
Previous Close | $4.00 | ||
Volume | 1,972,394 | ||
30-Day Average Volume | 1,795,864 | ||
1-Week Change | -3.68% | ||
1-Month Change | -6.43% | ||
1-Year Change | 23.58% | ||
3-Year Change | 73.89% | ||
5-Year Change | 3.15% | ||
Fundamentals | |||
Shares Outstanding | 125.5M | ||
Total Assets | $141.1M | ||
Market Cap | $504.3M | ||
Enterprise Value | $432.3M | ||
Period: QTR TTM FY | |||
Revenue | $500,000.00 | ||
Net Income | -$8.1M | ||
Free Cash Flow | -$14.9M | ||
EBIT | -$8.1M | ||
EBITDA | -$7.9M | ||
Net Working Capital | $98.4M | ||
EPS | -$0.07 | ||
Enterprise Value/EBITDA | -54 | ||
Enterprise Value/Revenue | 865 | ||
P/B | -15 | ||
P/E | -57 | ||
PEG | -1 | ||
Price/Free Cash Flow | -34 | ||
Price/Operating Cash Flow | -34 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue